Funding from The Parkinson Alliance helped to finance the following Parkinsons' research. Grantees were selected by scientific review committees of participating organizations. Reports are available by clicking the underlined grants.

23. Role of Survival of Motor Neuron Protein Apoptosis of Parkinson's Disease
Douglas Kerr, Ph.D.
John Hopkins University, School of Medicine

24. Tryosine Hydroxylase as a Cytotoxic Protein in Parkinson’s Disease
Donald M. Kuhn, Ph.D.
Wayne State University School of Medicine, Dept. of Psychiatry and Behavioral Neurosciences

25. Nurrl Gene and Parkinson's Disease
Wei-Dong Le, M.D., Ph.D.
Baylor College of Medicine, Dept. of Neurology

26. Magnetic Resonance Spectroscopy and Brain Energy Metabolism in Parkinson's Disease
W.R. Wayne Martin, M.D.
University of Alberta

27. Is There a Difference in Nigral Dopaminergic Neural Numbers Amongst Normal Individuals of Different Racial Origins?
Uday B. Muthane, M.D.
Nat. Inst. of Mental Health and Neurosc.
Susan E. Daniel, M.D.
PD Society Research Center Institute of Neurology

28. Neuronal Survival: The Role of Exitotoxicity and Apopotosis in Cultured and Grafted Dopamine Neurons
Gabriele S. Schierle, MSc
Wallenberg Neuroscience Center

29. The Functional Organization of the Primate Pallidum: Targets for Gene Based Therapy for Parkinson’s Disease
Jay S. Schneider, Ph.D.
Thomas Jefferson University, Jefferson Medical College

30. Gene Therapy in Rat Model of Parkinson's Disease
Michal K. Stachowiak, Ph.D.
The Research Foundation, State University New York

31. Characterization of the Role of Dopamine in the Primate Substania Nigra
Thyagarajan Subramanian
Emory University

32. Effect of Methionine and COMT Inhibitors in L -Dopa Neurotoxicity
Peter Werner, Ph.D.
Albert Einstein College of Medicine, Dept. of Neurology

33. New Approaches to Cell Transplantation in Parkinson’s Disease
Cristian Achim, M.D., Ph.D.
University of Pittsburgh, Dept. of Pathology

34. Developing a New Biosensor for Studies of Brain Chemistry
Michael Adrian, Ph.D.
University of Pittsburgh, Dept. of Chemistry

35. Gene Therapy for Parkinson's Disease-Increasing the Availability of Growth Factors
Martha Bohn, Ph.D.
Northwestern University, Dept. of Neurobiology

36. Acetycholinesterase and Glucose PET Imaging in Parkinsonism and Dementia
Nicolass Bohnen, M.D., Ph.D.
University of Pittsburgh, Dept. of Neurology

37. The Role of a Novel Protein in the Regulation of Dopamine Systems
Robert Bowser, Ph.D.
University of Pittsburgh, Dept. of Pathology

38. The Role of Glial Cells in Nerve Cell Degeneration
Patrick Card, Ph.D.
University of Pittsburgh, Dept. of Behavioral Neuroscience

39. Which Proteins are Involved in DA Cell Loss in Parkinson's Disease?
Charleen Chu, M.D., Ph.D.
University of Pittsburgh

40. Developing New Protections Against Oxidative Stress
Donald DeFranco, Ph.D.
University of Pittsburgh, Dept. of Biology

41. A New Detector for Analyzing Brain Chemistry
Terri Hastings, Ph.D.
University of Pittsburgh, Dept. of Neurology

42. Mapping the Impact of Parkinson's Disease on the Anatomy of the Brain
Susan Sesack, Ph.D.
University of Pittsburgh, Dept. of Behavioral Neuroscience

43. Can Physical Therapy Actually Repair the Brain?
Tim Schallert, Ph.D.
University of Texas, Dept. of Psychology

44. Searching for a New Source of Dopamine-Releasing Cells
Zuo-Zhong Wang, Ph.D.
University of Pittsburgh, Dept. of Neurobiology

45. Understanding and Controlling Incontinence in Parkinson’s Disease
Naoki Yoshimura, Ph.D., MD
University of Pittsburgh, Dept. of Pharmacology

46. Studies of Neurochemical Interactions in an Animal Model of Parkinson's Disease
Michael Zigmond, Ph.D.
University of Pittsburgh, Dept. of Neurology

47. The Biochemistry of Cell Death in an Animal Model of Parkinson's Disease
Michael Zigmond, Ph.D.
University of Pittsburgh, Dept. of Neurology


Return to 1998-1999 Pilot Study Grants - Grants 1-22

Return to Top